Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech

With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let’s have a look at some of the rulings, studies, and companies that made waves in the sector last week.

Perhaps no story headlined this past week more than the announcement (finally!) that Amgen, Inc. (NASDAQ:AMGN) would be purchasing Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) for $10.4 billion, or $125 a share. After multiple potential bidders dropped out of the running, only Amgen, Inc. (NASDAQ:AMGN) was left standing — and for just $5 more per share than its previous offer. To add icing on the cake to the deal, the EU approved Bayer and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)’s Stivarga on Friday for the treatment of metastatic colorectal cancer. My initial assessment of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) valued the company as high as $145 a share, thanks to strong forecasted growth from Kyprolis in treating multiple myeloma, so I’d certainly say Amgen, Inc. (NASDAQ:AMGN) is getting a pretty good deal.

Amgen, Inc. (NASDAQ:AMGN)

Shareholders in Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) aren’t complaining much, either, with shares rising by double digits after the company reported positive top-line results in a mid-stage study of SGI-110 for acute myeloid leukemia. Based on Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)’s press release, of the 67 patients treated in the trial, 25% demonstrated an overall complete remission rate — nine refractory and relapsed AML patients, and eight treatment-naive patients. Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) plans to release the full details of the study in December, but in the meantime, shareholders have plenty to cheer about.

Speaking of cheering and getting the pompons out, Pharmacyclics, Inc. (NASDAQ:PCYC) announced on Thursday that the Food and Drug Administration had accepted its new drug application filing for ibrutinib, an oral B-cell malignancy drug designed to treat mantle cell lymphoma and chronic lymphocytic leukemia. Not only did the FDA accept ibrutinib, but it’ll also receive a priority review, meaning it could make it to market even faster. The acceptance of Pharmacyclics, Inc. (NASDAQ:PCYC)’ NDA triggers a $75 million milestone payment from its licensing partner Johnson & Johnson.

But, just as we did last week, we’ll end on a sour note with Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), which reported on Monday that R343, an inhaled SYK inhibitor that was in mid-stage trials to treat allergic asthma, failed to meet its primary and secondary endpoints in the study. Although Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) noted that the drug was well tolerated, the primary endpoint of a pre-defined change in pre-bronchodilator FEV1 (a measure of how much air a patient can expel from their lungs within the first second) relative to the placebo was not met. As such, R343 will be shelved and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders will be forced to chalk up another disappointing study.

The article This Week in Biotech originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.The Motley Fool owns shares of, and recommends Johnson & Johnson.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 34 Smartest Countries in the World

The 10 Countries with the Highest Suicide Rates

The 10 Most Technologically Advanced Countries in the World

The 10 Safest Countries in the World to Live in Peace

The 10 Top Selling Smartphones in the World 2014

The 12 Biggest Shopping Centers in the World

The 10 Friendliest Countries in the World

Qihoo 360 Technology Co Ltd (QIHU), Actavis plc (ACT), Yahoo! Inc. (YHOO) Among 20 Long Ideas from Sohn Canada

The 10 Laziest Countries in the World

The 10 Most Polluted Countries in the World

The 10 Most Dangerous Cities in America 2014

The Top 10 Gold Producing Countries in the World

The 10 Tallest Buildings in the World

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!